Pag 1 . :
• Yondelis (trabectedin), from PharmaMar S.A., for the treatment of advanced soft tissue sarcoma. Yondelis is the 42nd orphan medicinal product to receive a positive opinion. EMEA review began on 16 August 2006 with an active review time of 210 days.